140 related articles for article (PubMed ID: 3138579)
1. In vitro susceptibility of piperacillin v timentin and ticarcillin.
Bremner DA
N Z Med J; 1987 May; 100(823):299-300. PubMed ID: 3138579
[No Abstract] [Full Text] [Related]
2. Comparative activity in vitro of ticarcillin and ticarcillin plus clavulanic acid against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter calcoaceticus.
Campos P; Vera A; Martin-Luengo F
Chemioterapia; 1987 Jun; 6(2 Suppl):77-8. PubMed ID: 3151358
[No Abstract] [Full Text] [Related]
3. Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1984 Feb; 13(2):121-8. PubMed ID: 6323375
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
Greenberg RN; Bollinger MR; Alivisatos MR
Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
[TBL] [Abstract][Full Text] [Related]
5. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia.
Traub WH; Spohr M
Chemotherapy; 1987; 33(5):340-6. PubMed ID: 3117502
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of clinical bacterial isolates to Timentin (ticarcillin/clavulanic acid).
Villiger JW
N Z Med J; 1986 Nov; 99(814):914. PubMed ID: 3492692
[No Abstract] [Full Text] [Related]
7. In vitro activity of timentin.
Thomas MG; Lang SD
N Z Med J; 1985 May; 98(779):403-4. PubMed ID: 3857527
[No Abstract] [Full Text] [Related]
8. Timentin resistance.
Masterton RG; Garner PJ; Harrison NA; Rainford DJ
Lancet; 1987 Oct; 2(8565):975-6. PubMed ID: 2889900
[No Abstract] [Full Text] [Related]
9. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
Monteil H; Jehl F
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818
[TBL] [Abstract][Full Text] [Related]
10. Comparative activities in vitro of timentin (ticarcillin/clavulanic acid) and ureidopenicillins against ampicillin-resistant clinical isolates.
Griffin KE; Slocombe B
J Chemother; 1989 Jul; 1(4 Suppl):267-9. PubMed ID: 16312396
[No Abstract] [Full Text] [Related]
11. [Effect of a ticarcillin-clavulanic acid (timentin) combination on bacteria resistant to ticarcillin].
Rouhan D; Le Noc P; Robert J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):461-5. PubMed ID: 3937121
[TBL] [Abstract][Full Text] [Related]
12. [Chemical structure, anti-bacterial activity and pharmacokinetics of penicillins].
Miyashita T; Ono Y; Kunii O
Nihon Rinsho; 1991 Oct; 49(10):2266-70. PubMed ID: 1660944
[No Abstract] [Full Text] [Related]
13. Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations.
Thomson KS; Weber DA; Sanders CC; Sanders WE
Antimicrob Agents Chemother; 1990 Apr; 34(4):622-7. PubMed ID: 2344169
[TBL] [Abstract][Full Text] [Related]
14. Comparison of disc-diffusion and plate-incorporation susceptibility testing of gram-negative bacilli to ticarcillin, piperacillin and ticarcillin/clavulanate.
Elston RA; Swann RA; Fraise A
J Antimicrob Chemother; 1989 Feb; 23(2):285-7. PubMed ID: 2708186
[No Abstract] [Full Text] [Related]
15. In vitro activity and disk susceptibility of Timentin: current status.
Fuchs PC; Barry AL; Jones RN
Am J Med; 1985 Nov; 79(5B):25-32. PubMed ID: 4073092
[No Abstract] [Full Text] [Related]
16. Timentin versus piperacillin in the therapy of serious urinary tract infections.
File TM; Tan JS; Salstrom SJ; Johnson L
Am J Med; 1985 Nov; 79(5B):91-5. PubMed ID: 4073102
[TBL] [Abstract][Full Text] [Related]
17. Timentin versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
Cox CE
J Antimicrob Chemother; 1986 May; 17 Suppl C():93-6. PubMed ID: 3636340
[TBL] [Abstract][Full Text] [Related]
18. Prediction of piperacillin-tazobactam susceptibility among Enterobacteriaceae, Pseudomonas aeruginosa, and other bacteria using ticarcillin-clavulanic acid, ceftazidime, and other broad-spectrum antimicrobial in vitro test results.
Jones RN; Sutton LD; Cantrell HF; Lankford RB
Diagn Microbiol Infect Dis; 1994 Nov; 20(3):143-9. PubMed ID: 7874881
[TBL] [Abstract][Full Text] [Related]
19. [In vitro study of the effects of a ticarcillin-clavulanic acid combination on Pseudomonas aeruginosa as a function of resistant phenotypes].
Thabaut A; Meyran M
Pathol Biol (Paris); 1985 May; 33(5):408-11. PubMed ID: 3929218
[TBL] [Abstract][Full Text] [Related]
20. Reduced susceptibility of a mucoid strain of Pseudomonas aeruginosa to lysis by ticarcillin and piperacillin.
Bolister N; Basker M; Hodges N; Marriott C
J Antimicrob Chemother; 1989 Oct; 24(4):619-21. PubMed ID: 2515190
[No Abstract] [Full Text] [Related]
[Next] [New Search]
